BlackRock Institutional Trust’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $372K | Hold |
213,649
| – | – | ﹤0.01% | 3490 |
|
|
2016
Q3 | $709K | Sell |
213,649
-3
| -0% | -$10 | ﹤0.01% | 3389 |
|
|
2016
Q2 | $919K | Sell |
213,652
-99,293
| -32% | -$427K | ﹤0.01% | 3328 |
|
|
2016
Q1 | $1.76M | Sell |
312,945
-6,183
| -2% | -$34.8K | ﹤0.01% | 3081 |
|
|
2015
Q4 | $5.49M | Buy |
319,128
+38,098
| +14% | +$655K | ﹤0.01% | 2670 |
|
|
2015
Q3 | $5.93M | Sell |
281,030
-9,318
| -3% | -$197K | ﹤0.01% | 2620 |
|
|
2015
Q2 | $14.4M | Sell |
290,348
-29,662
| -9% | -$1.47M | ﹤0.01% | 2149 |
|
|
2015
Q1 | $25.1M | Buy |
320,010
+2,138
| +0.7% | +$167K | ﹤0.01% | 1797 |
|
|
2014
Q4 | $19.3M | Sell |
317,872
-25,157
| -7% | -$1.52M | ﹤0.01% | 1936 |
|
|
2014
Q3 | $14.6M | Buy |
343,029
+27,749
| +9% | +$1.18M | ﹤0.01% | 2082 |
|
|
2014
Q2 | $19.5M | Buy |
315,280
+17,477
| +6% | +$1.08M | ﹤0.01% | 1977 |
|
|
2014
Q1 | $19.4M | Buy |
297,803
+14,590
| +5% | +$948K | ﹤0.01% | 1984 |
|
|
2013
Q4 | $15.9M | Buy |
283,213
+7,224
| +3% | +$407K | ﹤0.01% | 2107 |
|
|
2013
Q3 | $16.9M | Buy |
275,989
+10,081
| +4% | +$618K | ﹤0.01% | 1988 |
|
|
2013
Q2 | $15.5M | Buy |
+265,908
| New | +$15.5M | ﹤0.01% | 2006 |
|